EPND+ launches at #IHIForum2026, continuing the legacy of the EPND project. ACCESS-AD will build on EPND infrastructure to share clinical, imaging, biomarker & real-world data, advancing timely diagnosis, treatment & monitoring of Alzheimer’s disease www.eurekalert.org/news-release...

Innovative Health Initiative@ihieurope.bsky.social · 3d ago

🎉 The new entity EPND+ just launched at the #IHIForum2026! Born from an IMI2 project, EPND is now supporting 4 other IHI projects to develop data-driven solutions for #NeurodegenerativeDiseases. Find out more about it here: www.epndplus.org #HealthInnovation #HorizonEU

Our #EarlyCareerResearchers explained how older generation of scientists could learn from the younger one - Give younger researchers the space to talk. Mentorship is helpful. Tell us what you can deliver. Don't be afraid to say I don't know. Give opportunities to young researchers. #IHIForum2026

We’re delighted that our ACCESS-AD poster has been selected as a poster finalist 🎉 It’s wonderful to see #EarlyCareerResearchers sharing their projects and ideas at #IHIForum2026. Thank you @ihieurope.bsky.social for creating this opportunity! 👏

Innovative Health Initiative@ihieurope.bsky.social · 3d ago

Our #EarlyCareerResearchers are presenting their projects now in the plenary at the #IHIForum2026. Well done to the researchers from Thera4Care, @access-ad.bsky.social Inno4Vac, ICARE4CVD, PATH @edent1fi.bsky.social

We're looking forward to 2 inspiring days on translating research into long-term impact at @ihieurope.bsky.social #IHIForum26 🇧🇪 Some of our members will join discussions & Carolina Pamplona will present an ACCESS-AD poster. Stop by to learn more about our project www.ihi.europa.eu/news-events/...

🌟and that's a wrap!🌟 Today, we concluded two busy days for ACCESS-AD: our very first General Assembly, hosted in 🇳🇱 & bringing together colleagues from our 30 partner organisations. 👀 for a summary on the ACCESS-AD website - in the meantime, enjoy these team photos 💜 @ihieurope.bsky.social

Earlier this week, we launched ACCESS-AD 🚀 Today, we’re sharing a short video on how our @ihieurope.bsky.social project aims to support earlier diagnosis, safer treatment and better monitoring for #Alzheimer’s disease. 🎬 Watch the video to learn more and stay tuned!

👋 Say hello to new project @access-ad.bsky.social! They want to innovate how #AlzheimersDisease is diagnosed and treated in routine clinical practice - strengthening the care pathway with a vision of personalised care for every patient. #EUResearch #IHITransformingHealth #HealthInnovation

ACCESS-AD@access-ad.bsky.social · 9mo ago

👋Hello from ACCESS-AD! We’re delighted to launch ACCESS-AD, a new @ihieurope.bsky.social project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across Europe 🇪🇺 Read our press release: bit.ly/ACCESS-AD_la...

📣Follow @access-ad.bsky.social, a new @ihieurope.bsky.social project, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care. 👉 Visit the project's website for more information: access-ad.org

ACCESS-AD@access-ad.bsky.social · 9mo ago

👋Hello from ACCESS-AD! We’re delighted to launch ACCESS-AD, a new @ihieurope.bsky.social project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across Europe 🇪🇺 Read our press release: bit.ly/ACCESS-AD_la...

Today is the launch of @access-ad.bsky.social, a five-year @ihieurope.bsky.social project advancing timely diagnosis and equitable treatment for Alzheimer’s disease across Europe. We are delighted to be a partner in supporting this initiative together. Learn more here: bit.ly/ACCESS-AD_la...

ACCESS-AD: a new European initiative to accelerate timely and equitable AD diagnosis, treatment and care

Developed by a consortium of 30 public and private partners, ACCESS-AD (“Advancing Clinical Care and Equity through Scalable Solutions in Alzheimer’s Disease diagnosis and treatment”...

bit.ly

@access-ad.bsky.social builds on other @ihieurope.bsky.social initiatives including @ihi-prominent.bsky.social, @predictom.bsky.social, AD-RIDDLE and EPND, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care.

ACCESS-AD@access-ad.bsky.social · 9mo ago

👋Hello from ACCESS-AD! We’re delighted to launch ACCESS-AD, a new @ihieurope.bsky.social project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across Europe 🇪🇺 Read our press release: bit.ly/ACCESS-AD_la...

👋Hello from ACCESS-AD! We’re delighted to launch ACCESS-AD, a new @ihieurope.bsky.social project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across Europe 🇪🇺 Read our press release: bit.ly/ACCESS-AD_la...